The Grünenthal Group
The Grünenthal Group is an independent, family-owned, international research-based pharmaceutical company headquartered in Aachen, Germany.
We are an entrepreneurial specialist delivering true benefits to patients. By sustainably investing in research and development above the industrial average, we are committing to innovation in order to treat unmet medical needs and bring value-adding products to markets. Grünenthal is a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.
Life Science Leader - Cover Story
Grünenthal’s plan to expand globally & expand its pipeline
Grünenthal has the ambition to become a € 2 billion company – in an interview with Wayne Koberstein CEO Gabriel Baertschi reveals how Grünenthal will reach this goal by addressing high unmet needs in pain and beyond…